# Confirmatory Study of BK1310 in Healthy Infants

> **NCT03891758** · PHASE3 · COMPLETED · sponsor: **Tanabe Pharma Corporation** · enrollment: 267 (actual)

## Conditions studied

- Tetanus
- Diphtheria
- Pertussis
- Poliomyelitis
- Bacterial Meningitis

## Interventions

- **BIOLOGICAL:** DPT-IPV-Hib
- **BIOLOGICAL:** Hib vaccine
- **BIOLOGICAL:** DPT-IPV

## Key facts

- **NCT ID:** NCT03891758
- **Lead sponsor:** Tanabe Pharma Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-01
- **Primary completion:** 2019-09-18
- **Final completion:** 2020-08-10
- **Target enrollment:** 267 (ACTUAL)
- **Last updated:** 2026-01-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03891758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03891758, "Confirmatory Study of BK1310 in Healthy Infants". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT03891758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*